Extendicare Inc's stock has seen a notable uptick, gaining 2.42% in the last trading session, reflecting investor confidence in its growth trajectory.
On the TSX, Extendicare Inc (EXE.TO) closed at CA$33.82, marking a 2.42% increase from the previous day. This rise can be attributed to the company's ongoing expansion and strategic acquisitions in the home health care sector, which have bolstered its market position and earnings potential.
Advertisement
Earn cash back with a smarter spending account
Open a KOHO account and start earning on everyday purchases — no annual fee on the base plan.
Extendicare Inc
EXE.TO
EXE.TO
Extendicare Inc
WealthAwesomeMarket cap
$3.48B
P/E
26.1x
Div. yield
1.39%
Div. / share
$0.51
52W high
$39.09
52W low
$11.99
1W change
-7.56%
Beta
1.15
Analyst Price Targets
Based on analyst covering EXE
Wall Street analysts forecast EXE stock price to rise 9.5% over the next 12 months.
Consensus
Moderately BullishBased on avg. target vs last close (formal rating unavailable for Canadian listings)
Avg. Target
C$38.83
+9.5% Upside
Current Price
C$35.48
Last close
Analyst ratings and price targets are updated periodically. Not financial advice.
Wealth Awesome Price Forecast
WA ModelStatistical 90-day price range based on EXE's historical volatility
30-Day Vol
28.7%
Annualized
90-Day Vol
34.1%
Annualized
Trend (90d)
+50.0%
Annualized drift
90d Mean
C$42.42
Expected price
| Horizon | Expected | 68% Range (1σ) |
|---|---|---|
| 30 trading days | C$37.66 | C$34.11 – C$41.57 |
| 60 trading days | C$39.97 | C$34.75 – C$45.97 |
| 90 trading days | C$42.42 | C$35.74 – C$50.34 |
Methodology: Range is calculated using 30-day realized volatility via geometric Brownian motion (log-normal model). 68% band = ±1σ, 95% band = ±2σ. This is a statistical model, not a prediction. Past volatility does not guarantee future results. Not financial advice.
Investor takeaway: Investors should consider the implications of Extendicare's recent growth initiatives and financial performance, particularly in the context of the aging population and increasing demand for health care services.
Extendicare's Market Cap Reaches CA$3.09 Billion
Advertisement
With a market cap of CA$3.09 billion and a P/E ratio of 24.28, Extendicare is positioned as a key player in the health care sector, reflecting its growth potential amidst increasing demand.
Bull case
The recent acquisition of CBI Home Health for $570 million enhances Extendicare's service offerings in the home health care sector. This move is expected to significantly boost the company's earnings, especially as the demand for home health services continues to rise with an aging population. Additionally, a strong increase in adjusted EBITDA shows a positive growth trend. The company's decision to raise its dividend also signals confidence in its financial stability and long-term profitability.
Bear case
While the stock has risen, investors should stay cautious about potential market volatility. There are risks associated with the health care sector, including regulatory changes and economic pressures that could affect profitability.
Advertisement
Advertisement
Wealth Awesome
Timely coverage of Canadian stocks, earnings, dividends, and market movers for DIY investors. Stories are checked against exchange data and public filings.
View Full Profile →✅ Reviewed by Certified Financial Professionals
This content has been reviewed by CFA® charterholders and Certified Financial Planners (CFP®) with over a decade of experience in Canadian financial markets. All information is fact-checked against official Canadian sources and regulations.
Why these credentials matter: CFA® charterholders complete 900+ hours of rigorous study in investment analysis and ethics. CFP® professionals are held to the highest standards of financial planning competency and fiduciary duty in Canada.
⚠️ Professional Disclaimer
This content is for educational purposes only and should not be considered personalized financial advice. While our team brings professional expertise, individual circumstances vary. For personalized guidance, consult with a qualified financial advisor, tax professional, or mortgage specialist.
